JP Morgan Chase
DMRA

JP Morgan Chase’s Damora Therapeutics DMRA Stock Holding History

JP Morgan Chase’s Portfolio DMRA Stock Details DMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.8M Buy
+2,058,933
New +$49.9M ﹤0.01% 1481
2025
Q1 		– Sell
-100
Closed -$466 – 7461
2024
Q4 		$466 Buy
+100
New +$654 ﹤0.01% 6810
2024
Q3 		– Sell
-118
Closed -$1.41K – 7509
2024
Q2 		$1.41K Hold
118
– – ﹤0.01% 6569
2024
Q1 		$2.31K Buy
118
+84
+247% +$1.49K ﹤0.01% 6558
2023
Q4 		$611 Hold
34
– – ﹤0.01% 6901
2023
Q3 		$614 Hold
34
– – ﹤0.01% 6697
2023
Q2 		$2.15K Hold
34
– – ﹤0.01% 6324
2023
Q1 		$2K Hold
34
– – ﹤0.01% 6417
2022
Q4 		$1K Hold
34
– – ﹤0.01% 6408
2022
Q3 		$2K Hold
34
– – ﹤0.01% 6250
2022
Q2 		$1K Sell
34
-37
-52% -$1.7K ﹤0.01% 6353
2022
Q1 		$4K Buy
+71
New +$3.99K ﹤0.01% 6349

Other funds holding DMRA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
RCP
Remedium Capital Partners Fort Lauderdale, Florida $452M AUM

JP Morgan Chase's DMRA Position: Q2 2026 in Review

JP Morgan Chase opened a new position in Damora Therapeutics (DMRA) in Q2 2026: 2,058,933 shares worth $49.8M. The stake represents ﹤0.01% of the portfolio and ranks #1481 among its holdings. This is a return to the name: JP Morgan Chase previously reported a position in DMRA as recently as Q4 2024.

JP Morgan Chase first reported a position in DMRA in Q1 2022 and has held it in 12 quarters since. 104 funds tracked by Wall St. Rank hold DMRA as of Q2 2026.

  • JP Morgan Chase held 2,058,933 shares of Damora Therapeutics worth $49.8M as of Q2 2026.
  • Damora Therapeutics was a new JP Morgan Chase position in Q2 2026.
  • Damora Therapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #1481 holding.
  • JP Morgan Chase first reported a position in Damora Therapeutics in Q1 2022 and has held it in 12 quarters since.
  • 104 funds tracked by Wall St. Rank held Damora Therapeutics as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.